TFAOF yields 7.74% · JNJ yields 2.13%● Live data
📍 TFAOF pulled ahead of the other in Year 1
Combined, TFAOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TFAOF + JNJ for your $10,000?
O2 Czech Republic a.s. provides integrated telecommunication services for households, small and medium sized businesses, and corporations in the Czech Republic and Slovakia. It offers mobile telecommunication, data, and insurance services; electronic sales reporting solutions; and information and communication technology services, such as system integration, outsourcing, and software development, as well as project solutions. The company also offers fixed and mobile voice, data transmission, and Internet services; digital television; information technology; home security equipment and services; and financial services intermediary. In addition, it provides on-line communication platform; direct marketing platform; transport telematics services; software development; certification services; and auction sales and advisory services, as well as operates mobile virtual network for prepaid services, and startup funds. The company was formerly known as Telefónica Czech Republic, a.s. and changed its name to O2 Czech Republic a.s. in June 2014. O2 Czech Republic a.s. was incorporated in 1993 and is based in Prague, the Czech Republic. O2 Czech Republic a.s. is a subsidiary of PPF Telco B.V.
Full TFAOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.